Hypertriglyceridemia and plasma insulin in combined familial hyperlipidemia

被引:0
|
作者
Ascaso, JF [1 ]
Sales, J [1 ]
Merchante, A [1 ]
Real, JT [1 ]
Lorente, RI [1 ]
MartinezValls, J [1 ]
Carmena, R [1 ]
机构
[1] UNIV VALENCIA, HOSP CLIN, SERV ENDOCRINOL & NUTR, E-46003 VALENCIA, SPAIN
来源
REVISTA CLINICA ESPANOLA | 1997年 / 197卷 / 11期
关键词
combined familial hyperlipidemia; hyperinsulinism; lipids and insulin; plasma triglycerides; insulin;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Changes in insulin secretion were investigated in a group of non obese subjects with combined familial hyperlipidemia (CFH), with normal glucose tolerance, relating the observed changes with plasma triglycerides and lipoprotein phenotype. Materials and methods. The study was conducted with 21 subjects (16 males and 5 females; mean age: 45.9 +/- 9.1 years), diagnosed of CFH after the clinical and analytical study of patients and their first degree relatives (9 with phenotype IIa, 8 IIb, and 4 IV) and 21 healthy control subjects, of similar age, sex and body weight. In both groups, lipids, plasma lipoproteins, glucose, basal plasma insulin, and insulin after and oral glucose overload (OGO) were quantitated. Results. Diastolic blood pressure was higher (p < 0.01) in CFH group compared with controls (means: 132/80 vs 123/71 mmHg, respectively). TC, TG and Apo B were also higher in the CFH group. With OGO significantly higher serum insulin levels were observed at 0, 30, 60, 90 and 120 minutes in CFH subjects compared with control group. Basal serum insulin and the area under the curve of insulin secretion after OGO was higher in subjects with triglycerides (45,579 +/- 13,056 in controls, 61,385 +/- 22,254 in CFM IIa, 70,645 +/- 17,271 IIb and 124,884 +/- 36,944 in CFH IV. Insulin secretion correlated significantly (p < 0.01) with plasma triglycerides. As conclusion, hyperinsulinism is a finding in CFH non obese subjects and with normal glucose tolerance, and has an increasing frequency in subjects with high triglycerides levels.
引用
收藏
页码:735 / 739
页数:5
相关论文
共 50 条
  • [21] Low plasma vitamin A concentrations in familial combined hyperlipidemia
    Ribalta, J
    LaVille, AE
    Girona, J
    Vallvé, JC
    Masana, L
    CLINICAL CHEMISTRY, 1997, 43 (12) : 2379 - 2383
  • [22] HYPERTRIGLYCERIDEMIA IN STRAIN HCB19 MICE - A POTENTIAL MODEL OF FAMILIAL COMBINED HYPERLIPIDEMIA
    CASTELLANI, LW
    MEHRABIAN, M
    DEMANT, P
    CIRCULATION, 1994, 90 (04) : 188 - 188
  • [23] Specific insulin resistance of adipose tissue in Familial Combined Hyperlipidemia
    Pette, C
    Janssen, MA
    van der Kallen, CJH
    de Bruin, TWA
    CIRCULATION, 1999, 100 (18) : 196 - 196
  • [24] COMBINATION-DRUG THERAPY FOR TREATMENT OF PATIENTS WITH FAMILIAL COMBINED HYPERLIPIDEMIA RESULTING IN COMBINED HYPERTRIGLYCERIDEMIA AND HYPERCHOLESTEROLEMIA
    EAST, CA
    BILHEIMER, DW
    GRUNDY, SM
    CIRCULATION, 1986, 74 (04) : 200 - 200
  • [25] COMBINATION-DRUG THERAPY FOR TREATMENT OF PATIENTS WITH FAMILIAL COMBINED HYPERLIPIDEMIA RESULTING IN COMBINED HYPERTRIGLYCERIDEMIA AND HYPERCHOLESTEROLEMIA
    EAST, CA
    BILHEIMER, DW
    GRUNDY, SM
    ARTERIOSCLEROSIS, 1986, 6 (05): : A544 - A544
  • [26] Mutations of the human hepatic lipase gene in patients with combined hypertriglyceridemia/hyperalphalipoproteinemia and in patients with familial combined hyperlipidemia
    Gehrisch, S
    Kostka, H
    Tiebel, M
    Patzak, A
    Paetzold, A
    Julius, U
    Schroeder, HE
    Hanefeld, M
    Jaross, W
    JOURNAL OF MOLECULAR MEDICINE-JMM, 1999, 77 (10): : 728 - 734
  • [27] Mutations of the human hepatic lipase gene in patients with combined hypertriglyceridemia/hyperalphalipoproteinemia and in patients with familial combined hyperlipidemia
    S. Gehrisch
    H. Kostka
    M. Tiebel
    A. Patzak
    A. Paetzold
    U. Julius
    H.-E. Schroeder
    M. Hanefeld
    W. Jaross
    Journal of Molecular Medicine, 1999, 77 : 728 - 734
  • [28] Insulin resistance in familial combined hyperlipidemia and coronary heart disease
    Real, JT
    PRiego, A
    Martinez-Uso, I
    Ascaso, JF
    Carmena, R
    DIABETES, 2001, 50 : A145 - A145
  • [29] A major gene effect on fasting insulin and insulin sensitivity in familial combined hyperlipidemia
    Pihlajamäki, J
    Austin, M
    Edwards, K
    Laakso, M
    DIABETES, 2001, 50 (10) : 2396 - 2401
  • [30] In vitro lipolysis of human VLDL: Effect of different VLDL compositions in normolipidemia, familial combined hyperlipidemia and familial hypertriglyceridemia
    vanBarlingen, HHJJ
    Kock, LAW
    deMan, FHAF
    Erkelens, DW
    deBruin, TWA
    ATHEROSCLEROSIS, 1996, 121 (01) : 75 - 84